Vimarsana
Biggest News Aggregation in the World

Page 9 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds - Vimarsana News

Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds

Lonza Group AG / Key word(s): Bond/Financing Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds 06.11.2023 / 18...

Virginia Tech researchers develop new drug design framework to fight COVID-19 - Vimarsana News

Virginia Tech researchers develop new drug design framework to fight COVID-19

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

5 podcast episodes on the essentials of longevity, healthy aging—from the effects of exercise and alcohol to genetics - Vimarsana News

5 podcast episodes on the essentials of longevity, healthy aging—from the effects of exercise and alcohol to genetics

Looking to learn more about the factors that contribute to longevity and aging gracefully? Listen to these five podcast episodes for longevity hacks.

5 podcast episodes on the essentials of longevity, healthy aging—from the effects of exercise and alcohol to genetics - Vimarsana News

5 podcast episodes on the essentials of longevity, healthy aging—from the effects of exercise and alcohol to genetics

Looking to learn more about the factors that contribute to longevity and aging gracefully? Listen to these five podcast episodes for longevity hacks.

AstraZeneca's Tagrisso Drug Poised to Dominate Lung Cancer Small Molecule Market - Vimarsana News

AstraZeneca's Tagrisso Drug Poised to Dominate Lung Cancer Small Molecule Market

In the dynamic realm of oncology, the use of small-molecule drugs continues to play a crucial role in the treatment of lung cancer.